Home Applications 070259 Application 070259
Type ANDA
Sponsor MYLAN PHARMS INC Application Products# Product, Drug, Ingredient table Product Drug Ingredient Form Strength Reference drug Reference standard 001 TOLAZAMIDE TOLAZAMIDE TABLET;ORAL 250MG No No 003 TOLAZAMIDE TOLAZAMIDE TABLET;ORAL 500MG No No
Source provenance: Browse the complete Orange Book source catalog · source snapshot 44 .
Orange Book products# Current product rows page 1 of 1 · 2 matching rows.
Application-product, Trade name, Ingredient table Application-product Trade name Ingredient Strength Dosage form / route TE codes RLD / RS Approval date A070259-001 TOLAZAMIDE TOLAZAMIDE 250MG TABLET / ORAL 1986-01-02 A070259-003 TOLAZAMIDE TOLAZAMIDE 500MG TABLET / ORAL 1986-03-17
Observed Orange Book product history# Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.
Product history page 3 of 3 · 88 observed states.
Captured, Edition, Application-product table Captured Edition Application-product Trade name Strength Dosage form / route Product TE source text RLD / RS Approval date Source SHA-256 2022-10-28 04:53 UTC 2022-10 A070259-001 TOLAZAMIDE 250MG TABLET / ORAL 1986-01-02 f41ea6bd6efb…2022-10-28 04:53 UTC 2022-10 A070259-003 TOLAZAMIDE 500MG TABLET / ORAL 1986-03-17 f41ea6bd6efb…2022-09-29 23:25 UTC 2022-09 A070259-001 TOLAZAMIDE 250MG TABLET / ORAL 1986-01-02 e64feba35796…2022-09-29 23:25 UTC 2022-09 A070259-003 TOLAZAMIDE 500MG TABLET / ORAL 1986-03-17 e64feba35796…2022-07-09 03:26 UTC · 3 captures of this ZIP 2022-07 A070259-001 TOLAZAMIDE 250MG TABLET / ORAL 1986-01-02 cb3db0bc1861…2022-07-09 03:26 UTC · 3 captures of this ZIP 2022-07 A070259-003 TOLAZAMIDE 500MG TABLET / ORAL 1986-03-17 cb3db0bc1861…2026-07-26 02:55 UTC · 3 captures of this ZIP 2026-06 A070259-001 TOLAZAMIDE 250MG TABLET / ORAL 1986-01-02 a50c72e98297…2026-07-26 02:55 UTC · 3 captures of this ZIP 2026-06 A070259-003 TOLAZAMIDE 500MG TABLET / ORAL 1986-03-17 a50c72e98297…
Reported adverse events (FAERS/openFDA)# Adverse event summaries are temporarily unavailable. Other product information remains available.
NDC Listings For This Application# NDC listings for this application page 1 of 1 · 5 matching rows.
NDC, Name, Nonproprietary name table NDC Name Nonproprietary name Labeler Marketing category Status 0378-0217 Tolazamide tolazamide Mylan Pharmaceuticals Inc. ANDA Current 0378-0217 Tolazamide tolazamide Mylan Pharmaceuticals Inc. ANDA Current 0378-0551 Tolazamide tolazamide Mylan Pharmaceuticals Inc. ANDA Current 0378-0551 Tolazamide tolazamide Mylan Pharmaceuticals Inc. ANDA Current 55289-265 Tolazamide tolazamide PD-Rx Pharmaceuticals, Inc. ANDA Current